Is Methylprednisolone + Neomycin registered with the SFDA?

The SFDA human drug list (edition 4-2026, as published by the Council of Health Insurance) lists 0 valid registrations of Methylprednisolone + Neomycin.

Is Methylprednisolone + Neomycin approved by the US FDA?

Drugs@FDA lists 2 application product lines for Methylprednisolone + Neomycin, including NEO-MEDROL ACETATE (Discontinued); NEO-MEDROL (Discontinued).

Active substances

Methylprednisolone + Neomycin

SFDA 1
US FDA 2

Open in the medicines table

SFDA Saudi Arabia — SFDA human drug list

Trade name	Strength	Form · route	Pack	Public price	Type	Company	Status
NEO-MEDROL ACNE LOTION	2.5, 2.5 %	Lotion · Topical	1 Bottle	SAR 9.10	NCE · Prescription	PHARMACIA UPJOHN	Withdrawn by MAH · Not Marketed

US FDA United States — FDA approvals (Drugs@FDA)

Product	Strength	Form · route	Applicant	Status	First approved
NEO-MEDROL ACETATE	1%;EQ 3.5MG BASE/GM; 0.25%;EQ 3.5MG BASE/GM	cream · topical	PHARMACIA AND UPJOHN	Discontinued	7 Dec 1964
NEO-MEDROL	0.1%;EQ 3.5MG BASE/GM	ointment · ophthalmic	PHARMACIA AND UPJOHN	Discontinued

Components

Values as published by each source: SFDA human drug list (4-2026, as published by the Council of Health Insurance; indications from the CHI Daman Drug Formulary), Drugs@FDA, EMA medicines data, Health Canada Drug Product Database (Open Government Licence – Canada), CMS NADAC, NHS Drug Tariff Part VIIIA (NHSBSA Copyright, Open Government Licence v3.0), WHO Model List of Essential Medicines (CC BY 3.0 IGO; regrouped by active substance, not created by WHO), EMA PRAC, US FDA safety-related labeling changes and MHRA Drug Safety Update (Open Government Licence v3.0). Sources and reuse. Not a substitute for the official registers or the product information.